Most Popular in:

Skin Science

New in Skin Science (page 83 of 95)Sign up for this RSS Feed!

Nov
14
2007

Rosacea Can Be Caused by Excess Protein

Researchers now believe they have found a key mechanism that drives rosacea.

Nov
13
2007

Too Much Sugar May Cause Wrinkles

Experts now believe that a lifetime of overeating sugar can make skin dull and wrinkled.

Nov
12
2007

Researchers Map Genes Causing Dandruff, Other Skin Conditions

A team at Procter & Gamble Beauty sequenced the genome of Malassezia globosa, a fungus that grows on the skin of between 50-90% of the population.

Oct
30
2007

Broccoli May Help Fight Skin Cancer

Scientists have discovered that an extract of broccoli sprouts protects the skin against the sun's harmful ultraviolet rays.

Oct
24
2007

The Fitzpatrick Skin Type Classification Scale

The Fitzpatrick Skin Type Classification system was developed in 1975 by Harvard Medical School dermatologist Thomas Fitzpatrick, MD, PhD.

Oct
22
2007

Women More Likely Than Men to be Affected by Adult Acne

In particular, women experience acne at higher rates than their male counterparts across all age groups 20 years and older.

Oct
17
2007

Hot ingredient: Blackberry Leaf

Blackberry leaf extract could be the new ingredient in the fight against aging skin.

Oct
12
2007

More Than Half of Lipstick Contains Lead, Says Consumer Rights Group; CTFA Responds

According to the Campaign for Safe Cosmetics, lipstick manufactured in the United States contains surprisingly high levels of lead; CTFA states lead is naturally occurring.

Oct
03
2007

Hot Ingredient: Gemstones

Nearly 15 years after launching its first scent, Bulgari, a Roman jewelry firm, is set to enter the skin care market.

Sep
27
2007

Experimental Skin Cancer Drug Shows Promise

An experimental drug called STA-4783 may prove an effective new treatment for skin cancer, according to research presented Wednesday at a meeting of the European Cancer Organization in Barcelona, Spain.

The drug causes tumor cells to self-destruct by overloading them with oxygen. A study of 81 patients with advanced melanoma skin cancer found that the 28 who received the standard chemotherapy drug paclitaxel went an average of 1.8 months before their cancer worsened. The 53 patients who received paclitaxel plus STA-4783 went an average of 3.7 months before their cancer worsened, the Associated Press reported.

The study also found that patients who received the combination therapy survived an average of one year after diagnosis, compared with an average of 7.8 months for those who received only paclitaxel. The study was paid for by Synta Pharmaceuticals Corp. of Lexington, Mass., which developed STA-4783.

The new drug, which has no effect on normal cells, may also prove effective against other cancers, the AP reported.

HealthDay News, September 26, 2007